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OBJECTIVES A specific left atrial (LA) linear lesion concept for treatment of paroxysmal and permanent
atrial fibrillation (AF) was tested using intraoperative ablation with minimally invasive
surgical techniques.
BACKGROUND Curative treatment for patients with chronic AF is among the main challenges of
interventional electrophysiology.
METHODS Seventy patients (mean age 53  10 years) with drug-refractory persistent (n  28) or
paroxysmal (n  42) AF underwent intraoperative radiofrequency (RF) ablation using
video-assisted minimally invasive techniques via a right anterolateral minithoracotomy.
Contiguous lesion lines involving the mitral annulus and the orifices of the pulmonary veins
were placed with RF energy application under direct vision to prevent anatomically defined
LA re-entrant circuits.
RESULTS Mean follow-up was 18  7 months in patients with permanent AF and 18  5 months in
patients with paroxysmal AF. Antiarrhythmic drug treatment was instituted in patients with
postoperative atrial arrhythmias to allow “reverse electrical remodeling” and was discontinued
after three months. Six months following ablation, 93% of the patients were in sinus rhythm
in both groups, and after 12 months, 95% and 97%, respectively. As major complications, one
esophagus perforation and one circumflex coronary artery stenosis were observed.
CONCLUSIONS A pure linear lesion line concept confined to the left atrium targeting specifically at
elimination of anatomically defined LA “anchor” re-entrant circuits eliminated AF in 90%
of the patients treated with intraoperative ablation using minimally invasive surgical
techniques over a mean follow-up of 1.5 years. (J Am Coll Cardiol 2002;40:475–80)
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Curative treatment of chronic atrial fibrillation (AF) re-
mains one of the main challenges of interventional electro-
physiology. Given the complex electrophysiologic nature of
AF, interventional treatment strategies target pathophysio-
logic cornerstones of AF (i.e., the initiating or the main-
taining factors). Clinical electrophysiologic studies from
Haı¨ssaguerre et al. (1) clearly identified the critical role of
initiating foci-triggering episodes of paroxysmal AF.
See page 481
Cox et al. (2–4), in contrast, developed a complex surgical
technique for treatment of AF with multiple biatrial inci-
sions, pulmonary vein (PV) isolation and a critical mass
reduction with amputation of both atrial appendages. The
hypothesis of their concept was that elimination of all
hypothetical biatrial functional re-entrant circuits should
prevent the perpetuation of AF. Widespread application of
the surgical maze procedure may have been precluded by the
relatively time-consuming nature of this extensive opera-
tion, including median sternotomy, despite very high suc-
cess rates. Recently, modifications of the maze procedure
have been introduced with less extensive incisions and
partial replacement of surgical incisions with cryoablation or
radiofrequency (RF) energy application in addition to mitral
valve surgery (5–12).
In the present study, we describe a new concept of
intraoperative RF ablation using minimally invasive surgical
techniques without the need for median sternotomy as a
primary indication for curative treatment of paroxysmal and
persistent AF. The specific hypothesis underlying this
restricted pure linear lesion concept is that the elimination
of anatomically defined left atrial (LA) re-entrant circuits
involving the mitral annulus and the PV orifices should
prevent the perpetuation of paroxysmal and persistent AF.
METHODS
Study patients. Seventy patients with either persistent AF
(n  28) or paroxysmal (n  42) AF for more than two
years were included in this study (Table 1). In the group of
patients with paroxysmal AF, all patients had two or more
episodes per week lasting 12 h. As an inclusion criterion,
all patients were highly symptomatic despite multiple anti-
arrhythmic drug-treatment regimen, including class I and
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class III antiarrhythmic drugs (Table 1). Left heart cathe-
terization with coronary angiography, transthoracic and
transesophageal echocardiography as well as two 24-h elec-
trocardiograms (ECGs) were performed in all patients
before operation. All patients gave written informed consent
on the investigational nature of the procedure, which was
approved by the institutional review committee.
Surgical approach. All patients were operated on using a
video-assisted minimally invasive surgical approach via a
right anterolateral minithoracotomy. After femoro-femoral
cardiopulmonary bypass was established, direct aortic
clamping was performed using a transthoracic clamp (Chit-
wood clamp, Scanlan, St. Paul, Minnesota). Either ante-
grade cold crystalloid cardioplegia or cold blood cardioplegia
was applied for myocardial protection. The left atrium was
incised parallel to the interatrial groove anterior to the right
PVs, allowing access to the mitral annulus as well as
exposure of the orifices of the PVs.
RF ablation. The RF alternating current (500 kHz, mod-
ified HAT 200S; Osypka GmbH, Grenzach-Wyhlen, Ger-
many) was delivered in a unipolar mode between the
10-mm T-shaped tip electrode of a specially designed
ablation probe (Osypka GmbH) and a 10  16 cm external
backplate electrode. Temperature-guided energy applica-
tions were performed with a preselected catheter tip tem-
perature of 60°C. Based on catheter stability, induction of a
well-visualized lesion line, and achievement of the pre-
selected catheter tip temperature, the ablation probe was
stepwise withdrawn after 20 to 40 s.
The first part of the RF application protocol consisted of
placing a contiguous lesion line extending from the inferior
aspect of the mitral annulus (P3 segment of the posterior
leaflet) to the left PVs (Fig. 1). The second line connected
the left lower and upper PV orifices. From there, a third line
coupled the left and right upper PVs. Then, the right upper
and lower PV orifices were connected. Care was taken to
advance the tip of the ablation probe only a few millimeters
inside the proximal funnel-shaped parts of the PVs. Finally,
the line at the left atrial roof was connected to the surgical
incision to prevent “incisional re-entry.”
Postoperative management and follow-up. All patients
were monitored with continuous ECG recordings for the
first three postoperative days. Daily 12-lead ECGs and two
24-h ECGs were performed within the first 10 postopera-
tive days. In addition, both transthoracic and transesopha-
geal echocardiography were performed between postopera-
tive days 5 and 10. In cases of recurrence of AF or atypical
LA flutter, electrical cardioversion followed by antiarrhyth-
mic drug treatment (class Ic or amiodarone) was instituted.
According to the study protocol, antiarrhythmic drug treat-
ment was withdrawn three months after operation.
All patients were seen in the outpatient clinic at 6 weeks,
3 months, 6 months and 12 months after operation.
Twelve-lead ECG, 24-h ECG, and echocardiography were
performed in all patients during each follow-up visit. All
patients and referring physicians were instructed to docu-
Abbreviations and Acronyms
AF  atrial fibrillation
ANOVA  analysis of variance
ECG  electrocardiogram
LA  left atrial
PTCA  percutanous transluminal coronary
angioplasty
PV  pulmonary vein
RF  radiofrequency
Table 1. Clinical Characteristics of the Study Patients
Persistent AF
(Group I)
(n  28)
Paroxysmal AF
(Group II)
(n  42)
p
Value
Age (yrs) 52  10 53  10 NS
AF history (yrs) 6  4 8  4 NS
Antiarrhythmic drug trials, n 5  3 4  3 NS
Arterial hypertension, n (%) 5 (18) 5 (12) NS
History of myocarditis, n (%) 3 (11) 2 (5) NS
Coronary artery disease, n (%) 0 2 (5) NS
Lone AF, n (%) 20 (71) 33 (79) NS
LA diameter (mm) 4.6  0.6 4.2  0.4 NS
Ejection fraction (%) 59  7 61  7 NS
Data are expressed as either mean  SD or number and percentage of patients.
AF  atrial fibrillation; LA  left atrial.
Figure 1. Schematic drawing of the left atrium and the geometry of the
radiofrequency (RF) energy-induced left atrial (LA) linear lesion lines for
treatment of atrial fibrillation (AF). The first lesion line extended from the
inferior aspect of the mitral annulus (MA) to the left pulmonary veins
(PVs). The second line connected the left lower pulmonary vein (LLPV)
and left upper pulmonary vein (LUPV) orifices. From there, a third line
coupled the left and right PVs. Then, the right upper pulmonary vein
(RUPV) and right lower pulomary vein (RLPV) orifices were connected.
Care was taken to advance the tip of the ablation probe only a few
millimeters inside the proximal funnel-shaped parts of the PVs. Finally, the
line at the LA roof was connected to the surgical incision to prevent
“incisional reentry.” This specific linear lesion line concept tested the
hypothesis of targeting the perpetuation of chronic AF by elimination of
anatomically defined “anchor” re-entrant circuits within the left atrium in
contrast to functionally determined re-entrant circuits and in contrast to
treating the initiating triggers of AF. The dotted line indicates the LA
incision.
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ment on the ECG if recurrences of an arrhythmia were
suspected. Oral anticoagulant therapy was prescribed for at
least three months.
Statistical analysis. Quantitative data were expressed as
mean  SD. Statistical comparisons were performed after
analysis of variance (ANOVA) for repeated measurements.
Statistical analysis was performed using ANOVA for re-
peated measures, the Student t test for single comparisons
and chi-square analysis. Differences were considered signif-
icant at p values  0.05.
RESULTS
Operative course. The overall operation time in patients
with persistent AF (group 1) measured 134  38 min, and
in patients with paroxysmal AF it was 137  35 min,
respectively (NS), and the aortic cross-clamp times were 44
 20 min and 43  15 min, respectively (NS). The
antiarrhythmic treatment time for induction of the lesion
lines measured 18  5 min and 16  4 min, respectively
(NS).
Rhythmologic course during in-hospital period. In
18/28 patients (64%) with persistent AF (group I), AF or
atypical atrial flutter occurred between the 2nd and 10th
postoperative days compared to 16/42 patients (38%) with
paroxysmal AF (group II) (p  0.05). All patients with
atrial tachyarrhythmias were electrically cardioverted and/or
treated with antiarrhythmic drugs (class Ic or amiodarone).
At the day of hospital discharge, 24/28 patients (86%) in
group I and 40/42 patients in group II (95%) were in sinus
rhythm, respectively (NS). The patients of groups I and II
were discharged 12  6 days and 10  3 days after
operation, respectively (NS).
Rhythmologic course and antiarrhythmic treatment dur-
ing follow-up. Mean follow-up in patients with persistent
AF (group I) was 18  7 months (range 10 to 31 months),
and in patients with paroxysmal AF (group II) 17  5
months (range 11 to 31 months) (NS) (Fig. 2). All patients
had a follow-up period of at least six months. After six
weeks, 25/28 patients (89%) of group I and 38/42 patients
(90%) of group II were in sinus rhythm, respectively (NS),
and after three months, 25/28 (89%) of group I and 39/42
patients (93%) of group II, respectively (NS) (Fig. 2). After
6 and 12 months, 26/28 patients (93%) and 18/19 patients
(95%) in group I and 39/42 patients (93%) and 34/35
patients (97%) in group II were in stable sinus rhythm,
respectively (NS).
In group I, 18/28 patients (64%) were discharged on
antiarrhythmic drugs compared to 16/42 patients (38%) in
group II (p  0.05) (Fig. 2). The percentage of patients of
group I (persistent AF) on antiarrhythmic drugs declined
over time and measured 68% after 6 weeks, 61% after 3
months, 26% after 6 months and 38% after 12 months. The
percentage of patients of group II (paroxysmal AF) on
antiarrhythmic drugs was 45% after 6 weeks (p  0.05
compared to group I), 43% after 3 months (p  0.05
compared to group I), 23% after 6 months (NS compared to
group I) and 14% after 12 months (NS compared to
group I).
One patient of group I underwent RF catheter ablation of
the inferior isthmus for treatment of typical atrial flutter,
and two patients had catheter ablation for gap-related LA
flutter during follow-up. One patient of group II underwent
RF catheter ablation of ectopic atrial tachycardia, and one
patient had catheter ablation of gap-related LA flutter
during follow-up.
Complications. One patient developed neurologic and
septicemic symptoms. In this patient, a fistula was found
between the esophagus and the left atrium, requiring reop-
eration on the 10th postoperative day. An additional reop-
eration was necessary owing to a fistula involving the left
bronchus system with subsequent left-sided pneumectomy.
One patient complained of angina pectoris six weeks after
operation. Coronary arteriography revealed a significant
stenosis of the circumflex coronary artery requiring percu-
taneous transluminal coronary angioplasty (PTCA) and
stent implantation.
Figure 2. Rhythm outcome after intraoperative ablation of paroxysmal atrial fibrillation (solid bars) and permanent (open bars) atrial fibrillation. AA 
percentage of patients on antiarrhythmic drugs; SR  sinus rhythm.
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Minor bleeding complications were observed in an addi-
tional two patients. No mortality was observed during the
complete follow-up period, and no patient was lost to
follow-up.
Echocardiographic data. Preoperative LA diameter on
echocardiography was slightly larger in patients with per-
sistent AF (group I) compared with patients with paroxys-
mal AF (group II) (4.6  0.6 mm vs. 4.2  0.4 mm, NS).
Data on mitral valve E/A ratio and LA appendage velocity
are given in Figure 3.
DISCUSSION
Main findings. A restrictive pure linear lesion approach
confined to the left atrium targeting at elimination of
anatomically defined LA re-entrant circuits eliminated AF
in more than 90% of the patients treated over a mean
follow-up period of 1.5 years. Placement of strategic con-
tiguous linear lesions under direct vision allowed validation
of a treatment strategy targeting at modification of the
arrhythmia substrate irrespective of trigger elimination or
critical mass reduction.
Curative treatment concepts for AF. Clinical electro-
physiologic studies from Haı¨ssaguerre et al. (1) clearly
identified the critical role of initiating foci-triggering epi-
sodes of paroxysmal AF. These triggers have been found in
the majority of cases in the area of the PV orifices, but they
may also be located in several other areas of both atria.
Radiofrequency catheter ablation directly targeting the ac-
tive foci or ostial disconnection of the PV muscle strands
may result in curative treatment of a substantial portion of
patients with paroxysmal AF, although high recurrence
rates have been recently reported (1,13,14).
In contrast to the initiating triggers, a modification of the
maintaining substrate may be necessary for treatment of
persistent AF and for patients with prolonged episodes of
paroxysmal AF. The hypothesis of the surgical maze pro-
cedure was the elimination of all hypothetical biatrial
functional re-entrant circuits to prevent the perpetuation of
AF (2–4). This could be realized with multiple biatrial
incisions, PV isolation and a critical mass reduction using
amputation of both atrial appendages. The extensive maze
procedure proved to be effective in patients with persistent
AF. Subsequently, the linear lesion line concept for modi-
fication of the substrate maintaining the arrhythmia was
adopted by interventional electrophysiologists for treatment
of chronic AF (15,16).
Significant problems have been faced with long procedure
times and substantial risks, including systemic thromboem-
bolism. Recently, Haı¨ssaguerre et al. (17) summarized their
experience with septal and LA linear ablation for treatment
of AF in 44 patients. A mean of 2.7 procedures per patient
were necessary to treat 25 patients (57%) successfully
without antiarrhythmic drugs. However, the mean cumula-
tive duration of procedures measured about 10 h and
fluoroscopy times close to 3 h, respectively, in their study
(17).
The role of electroanatomic mapping has been investi-
gated for induction of linear lesions in patients with AF,
with divergent results (18,19). The geometries of the lesions
that have been applied percutaneously so far seem to be
empirical, and validation of lesion geometry concepts with
percutaneous means is difficult. Consequently, clinical fail-
ure of percutaneously placed lesion lines may be the result of
insufficient lesion extension and/or geometry, or ablation
failure may be due to the insufficient realization of the
proposed lesion lines—that is, the induction of noncontig-
uous lesions without achievement of linear conduction
block. Therefore, in contrast to trigger elimination, no
specific pure linear lesion line concepts targeting the per-
petuation of AF could be validated percutaneously in a
substantial patient series with persistent AF.
In the present study, the operation theater on one side
and RF energy application on the other side were combined
to test a new concept of intraoperative RF ablation of
chronic AF aiming at a modification of the maintaining
substrate. A purely LA approach of intraoperative RF
energy application was applied that was restricted to elim-
inate LA anatomically determined macro–re-entrant “an-
chor” circuits involving the PVs and the mitral annulus. The
hypothesis behind this approach was that anatomically
defined reentrant circuit are especially “helpful” to maintain
AF because they may be more stable in contrast to purely
functionally determined but more unstable circuits.
Patients with chronic persistent AF revealed significantly
more AF relapses in the early postoperative period and more
often needed antiarrhythmic drug treatment, which might
be explained by the further developed arrhythmia substrate.
In patients with early relapses of AF, antiarrhythmic med-
ication with previously ineffective drugs was instituted and
then finally withdrawn after three months in most patients.
The rationale for this concept was to stabilize the atria
during the phase of “reverse electrical remodeling.” Inter-
estingly, the long-term success rate was equally high in
patients with previously persistent and paroxysmal AF.
Therefore, the concept of strategically placed linear lesion
lines targeting at the perpetuation of AF by elimination of
anatomically defined LA re-entry proved to be highly
effective in this patient cohort, with success rates exceeding
90%. In addition, normalized LA mechanical transport
function could be documented in all patients with postop-
erative sinus rhythm.
Intraoperative RF ablation as a primary indication for
curative treatment of persistent and paroxysmal AF using
minimally invasive surgical techniques without the need for
median sternotomy was shown to be feasible, with a mean
operation time of 2 h. The judgment on the efficacy-risk
profile of this highly invasive therapy needs to consider the
inherent risks of RF-induced linear lesions within the left
atrium. A high degree of surgical expertise, with minimally
invasive surgical techniques together with close cooperation
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Figure 3. Echocardiographic data on left atrial (LA) diameter, E/A ratio at mitral valve and flow velocity within the left atrial appendage (LAA) following
intraoperative ablation of atrial fibrillation. Open bars  permanent atrial fibrillation; Solid bars  paroxysmal atrial fibrillation.
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with interventional electrophysiologists, is a prerequisite for
this interdisciplinary treatment modality.
Study limitations, complications and future perspectives.
In the present study, 70 consecutive patients with highly
symptomatic, drug-resistant persistent or paroxysmal AF
underwent intraoperative ablation. Two significant compli-
cations were observed. The patient with a circumflex coro-
nary artery stenosis underwent PTCA and stent implanta-
tion and had an uneventful follow-up. The other patient
developed a fistula between the esophagus and the left
atrium, as well as a fistula to the left bronchus system that
required two reoperations. The complications in both pa-
tients are most likely directly related to RF energy applica-
tion within the left atrium. The complication regarding the
esophagus resulted in a slight but specific modification of
the surgical procedure—that is, compresses are now inserted
in the pericardial space separating the LA wall from the
esophagus, thereby preventing RF energy penetration to-
ward the esophagus.
Currently, no widespread application of a curative treat-
ment of persistent AF exists. The extensive maze operation
and its modifications have good results, but they require
long operation times and median sternotomy, thus preclud-
ing widespread application as a primary indication for AF
operation (5–12). Percutaneous catheter ablation, in con-
trast, seems to be feasible for patients with paroxysmal AF,
but no substantial data are available for patients with
persistent AF as the linear lesion line concept is not yet
practicable when applied percutaneously. In addition, no
pure linear lesion concept targeting at modification of the
substrate irrespective of triggers has been validated percu-
taneously thus far. The present study is not a modification
of the maze operation but follows a completely different
pathophysiologic concept, namely the prevention of ana-
tomically defined LA re-entrant circuits without mass
reduction and without treatment of potential triggers. Ap-
plying this concept with minimally invasive surgical means
without median sternotomy showed success rates exceeding
90% during a mean follow-up of 1.5 years. In addition, LA
mechanical transport function normalized in all patients,
with postoperative sinus rhythm allowing discontinuation of
oral anticoagulant therapy. In the future, this intraopera-
tively validated strategic linear lesion line concept might be
transferred to catheter ablation, provided that new naviga-
tion and catheter technologies will allow the transfer to
percutaneous ablation techniques.
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